Biopharmaceutical Engineering

Pharmaceutical and Biopharmaceutical manufacturing are key sectors in the Irish economy generating over 50 per cent of GDP. This sector has seen continued and sustained success with a number of high-profile investments in recent years providing excellent job opportunities for graduates. The programme and its academic faculty are closely linked with the National Institute for Bioprocessing Research and Training (NIBRT), which is a global centre of excellence for training and research in bioprocessing.



The MEngSc in Biopharmaceutical Engineering programme provides substantial coverage of scientific, technical, management and regulatory issues associated with this industry. The aim of this programme is to offer an internationally recognised high-quality flexible curriculum, which follows the latest developments in science and technology. This programme is suitable for Science and Engineering graduates wishing to obtain a qualification which is highly relevant to the biopharmaceutical industry.



This programme has an excellent employment record. It equips graduates with an internationally recognised qualification and the knowledge and skills to obtain a high level professional career in the Biopharmaceutical, Pharmaceutical and related sectors.

Stage 1 - Core

Principles of Biopharmaceutical Engineering (FT)CHEN40020

Animal Cell Culture Technology (FT)CHEN40040

Bioprocessing LaboratoryCHEN40090

Facility Design and OperationCHEN40110

Biopharmaceutical Industry Regulation and ManagementCHEN40120

Biopharmaceutical Engineering ProjectCHEN40140

Downstream ProcessingCHEN40460

Bioprocess DesignCHEN40530

Bioanalytical Science for BiopharmaCHEN40630

Data Sci for Biopharm ManufactCHEN40770

Research Methodology FTCHEN40890



Stage 1 - Option

Bioprocess Scale-up and Technology TransferCHEN40130

Gene Ther & Vacc Tech & ProcCHEN40860

GMP Manufact Advan TherapeuticCHEN40870

An honours undergraduate degree (NFQ level 8) with a minimum upper second class honours or international equivalence in a relevant Engineering, Science or Technology programme. However, all applicants will be assessed on a case-by-case basis and relevant or extensive work experience will be taken into account.



Applicants whose first language is not English must also demonstrate English language proficiency of IELTS 6.5 (no band less than 6.0 in each element), or equivalent.



These are the minimum entry requirements – additional criteria may be requested for some programmes

The following entry routes are available:



MEngSc Biopharmaceutical Engineering FT (T070)

Duration 1 Years Attend Full Time

Deadline Rolling*



* Courses will remain open until such time as all places have been filled, therefore early application is advised



The following entry routes are available:



The following entry routes are available:



MEngSc Biopharmaceutical Engineering PT (T015)

Duration 2 Years

Attend Part Time

Deadline Rolling*



* Courses will remain open until such time as all places have been filled, therefore early application is advised

90

1 year full-time, 2 years part-time.

MODE OF DELIVERY: Face-to-Face

MEngSc Biopharmaceutical Engineering (T070) Full Time

EU fee per year - € 8085

nonEU fee per year - € 25600


***Fees are subject to change


Please note that UCD offers a number of graduate scholarships for full-time, self-funding international students, holding an offer of a place on a UCD graduate degree programme. For further information please see http://www.ucd.ie/global/study-at-ucd/scholarshipsfinances/scholarships/.


The College of Engineering & Architecture also offer scholarships for non-EU students, for more information see: www.ucd.ie/eacollege/study/noneuscholarships.

Next Intake: 2024/2025 September.

Career & Graduate Study Opportunity

Your career opportunities upon graduation from this programme are exemplary. Ireland is a world player in pharmaceutical and biopharmaceutical production.



The pharmaceutical industry in Ireland comprises a mix of international and local companies. Approximately, 120 overseas companies have plants in Ireland, including many of the largest pharmaceutical and biopharmaceutical companies in the world including AbbVie, Amgen, Biomarin, BMS, Genzyme, GSK, Janssen Biologics (Ireland), Merck, Novartis, Pfizer, Regeneron, Roche, Sanofi Shire, and many more. Upon graduation from this programme, you will enjoy an extremely high job placement rate with superlative career opportunities.